Unveiling neoadjuvant chemotherapy-induced immune landscape remodeling and metabolic reprogramming in lung ...
Lung cancer is the most common cancer among all human tumor types, with more than 1.7×106 new cases worldwide each year. According to the Global Cancer Report data, lung adenocarcinoma (LUAD) accounts for most lung cancers (1). The application of adjuvant …